(+)-dexrazoxane decreases expression ISO Atp5f1a (Mus musculus) 6480464 Dexrazoxane results in decreased expression of ATP5F1A mRNA CTD PMID:26873546 (R)-adrenaline increases expression EXP 6480464 Epinephrine results in increased expression of ATP5F1A protein CTD PMID:19464573 (S)-nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ATP5F1A protein CTD PMID:28681937 (Z)-3-butylidenephthalide increases expression ISO ATP5F1A (Homo sapiens) 6480464 butylidenephthalide results in increased expression of ATP5F1A protein CTD PMID:23770345 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of ATP5F1A protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO Atp5f1a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ATP5F1A mRNA CTD PMID:22206623 1,2-dimethylhydrazine multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5F1A mRNA CTD PMID:22206623 1-chloro-2,4-dinitrobenzene affects binding ISO ATP5F1A (Homo sapiens) 6480464 Dinitrochlorobenzene binds to ATP5F1A protein CTD PMID:32991956 17alpha-ethynylestradiol increases expression ISO Atp5f1a (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of ATP5F1A mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO Atp5f1a (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of ATP5F1A mRNA CTD PMID:17555576 17alpha-ethynylestradiol multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1A mRNA CTD PMID:17942748 17beta-estradiol increases expression ISO ATP5F1A (Homo sapiens) 6480464 Estradiol results in increased expression of ATP5F1A mRNA CTD PMID:11179685 17beta-estradiol multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 3 more ... CTD PMID:11179685 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO ATP5F1A (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5F1A protein] CTD PMID:21136691 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Estradiol results in increased expression of ATP5F1A mRNA] CTD PMID:11179685 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ATP5F1A mRNA and Tetrachlorodibenzodioxin inhibits the reaction [AHR protein binds to ATP5F1A protein] CTD PMID:17942748 and PMID:21616089 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Atp5f1a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of ATP5F1A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects localization ISO Atp5f1a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the localization of ATP5F1A protein CTD PMID:21616089 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Atp5f1a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ATP5F1A mRNA CTD PMID:21570461 and PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5F1A mRNA CTD PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of ATP5F1A protein CTD PMID:16548065 2,4,6-tribromophenol decreases expression ISO ATP5F1A (Homo sapiens) 6480464 2 more ... CTD PMID:31675489 2,4-dibromophenyl 2,4,5-tribromophenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:19954255 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression EXP 6480464 2 more ... CTD PMID:19954255 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of ATP5F1A mRNA CTD PMID:21346803 2-tert-butylhydroquinone multiple interactions EXP 6480464 2-tert-butylhydroquinone inhibits the reaction [thallium nitrate results in decreased expression of ATP5F1A protein] CTD PMID:31726083 3,3',5,5'-tetrabromobisphenol A decreases expression ISO ATP5F1A (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of ATP5F1A protein CTD PMID:31675489 3,3'-diindolylmethane multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 3 and 3'-diindolylmethane inhibits the reaction [Estradiol results in increased expression of ATP5F1A mRNA] CTD PMID:11179685 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin analog results in increased expression of ATP5F1A protein CTD PMID:26597043 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP5F1A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO ATP5F1A (Homo sapiens) 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ATP5F1A protein CTD PMID:34186270 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5F1A mRNA CTD PMID:36041667 4-hydroxynon-2-enal affects binding ISO ATP5F1A (Homo sapiens) 6480464 4-hydroxy-2-nonenal binds to ATP5F1A protein CTD PMID:19374891 5-Hydroxythalidomide affects binding ISO ATP5F1A (Homo sapiens) 6480464 5-hydroxythalidomide binds to ATP5F1A protein CTD PMID:27464947 5-Hydroxythalidomide affects binding ISO Atp5f1a (Mus musculus) 6480464 5-hydroxythalidomide binds to ATP5F1A protein CTD PMID:27464947 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of ATP5F1A mRNA CTD PMID:30047161 7,12-dimethyltetraphene increases expression EXP 6480464 9 more ... CTD PMID:22248470 7,12-dimethyltetraphene multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 7H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of ATP5F1A protein CTD PMID:19464573 9H-xanthine multiple interactions EXP 6480464 [Xanthine co-treated with XDH protein] results in decreased expression of ATP5F1A protein CTD PMID:19464573 acrolein affects metabolic processing ISO Atp5f1a (Mus musculus) 6480464 Acrolein affects the metabolism of ATP5F1A protein CTD PMID:17921335 aldehydo-D-glucose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 alpha-D-galactose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 amitrole increases expression EXP 6480464 Amitrole results in increased expression of ATP5F1A mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ATP5F1A mRNA CTD PMID:16483693 amphetamine decreases expression ISO Atp5f1a (Mus musculus) 6480464 Amphetamine results in decreased expression of ATP5F1A protein CTD PMID:23459167 amphetamine multiple interactions ISO Atp5f1a (Mus musculus) 6480464 Amphetamine promotes the reaction [MDK gene mutant form results in decreased expression of ATP5F1A protein] and Amphetamine promotes the reaction [PTN gene mutant form results in decreased expression of ATP5F1A protein] CTD PMID:23459167 arsenous acid decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ATP5F1A mRNA CTD PMID:15949261 arsenous acid decreases expression ISO Atp5f1a (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of ATP5F1A mRNA CTD PMID:19422848 atrazine decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Atrazine results in decreased expression of ATP5F1A mRNA CTD PMID:22378314 and PMID:27114639 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of ATP5F1A mRNA CTD PMID:27114639 benzo[a]pyrene increases expression ISO Atp5f1a (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ATP5F1A mRNA CTD PMID:22228805 benzo[a]pyrene affects methylation ISO ATP5F1A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of ATP5F1A 5' UTR CTD PMID:27901495 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ATP5F1A mRNA CTD PMID:25181051 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5F1A mRNA CTD PMID:36041667 bisphenol A decreases expression ISO ATP5F1A (Homo sapiens) 6480464 bisphenol A results in decreased expression of ATP5F1A protein CTD PMID:31675489 and PMID:34186270 bisphenol A increases expression ISO ATP5F1A (Homo sapiens) 6480464 bisphenol A results in increased expression of ATP5F1A mRNA CTD PMID:33670352 bisphenol A affects expression ISO ATP5F1A (Homo sapiens) 6480464 bisphenol A affects the expression of ATP5F1A mRNA CTD PMID:30903817 Bisphenol B increases expression ISO ATP5F1A (Homo sapiens) 6480464 bisphenol B results in increased expression of ATP5F1A protein CTD PMID:34186270 bisphenol F multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP5F1A mRNA CTD PMID:28628672 bisphenol F increases expression ISO ATP5F1A (Homo sapiens) 6480464 bisphenol F results in increased expression of ATP5F1A protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of ATP5F1A mRNA CTD PMID:36041667 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of ATP5F1A protein CTD PMID:21699967 cadmium dichloride multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP5F1A mRNA] CTD PMID:36493885 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of ATP5F1A mRNA CTD PMID:21297351 and PMID:36493885 calycosin multiple interactions ISO Atp5f1a (Mus musculus) 6480464 7 and 3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein] CTD PMID:36436616 calycosin increases expression EXP 6480464 7 and 3'-dihydroxy-4'-methoxyisoflavone results in increased expression of ATP5F1A mRNA CTD PMID:36436616 calycosin multiple interactions EXP 6480464 7 more ... CTD PMID:36436616 cannabidiol decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Cannabidiol results in decreased expression of ATP5F1A protein CTD PMID:34122009 carbon nanotube decreases expression ISO Atp5f1a (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 CGP 52608 multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ATP5F1A gene] CTD PMID:28238834 chloropicrin decreases expression ISO ATP5F1A (Homo sapiens) 6480464 chloropicrin results in decreased expression of ATP5F1A mRNA CTD PMID:26352163 chromium(6+) decreases expression ISO ATP5F1A (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of ATP5F1A protein CTD PMID:22886373 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of ATP5F1A protein CTD PMID:22023808 clobetasol increases expression ISO Atp5f1a (Mus musculus) 6480464 Clobetasol results in increased expression of ATP5F1A mRNA CTD PMID:27462272 cocaine affects expression ISO ATP5F1A (Homo sapiens) 6480464 Cocaine affects the expression of ATP5F1A protein CTD PMID:19393250 copper atom decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1A mRNA CTD PMID:22465980 copper(0) decreases expression EXP 6480464 Copper results in decreased expression of ATP5F1A mRNA CTD PMID:22465980 copper(II) sulfate decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of ATP5F1A mRNA CTD PMID:19549813 D-glucose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 decabromodiphenyl ether decreases expression ISO ATP5F1A (Homo sapiens) 6480464 decabromobiphenyl ether results in decreased expression of ATP5F1A protein CTD PMID:31675489 dexamethasone decreases expression ISO Atp5f1a (Mus musculus) 6480464 Dexamethasone results in decreased expression of ATP5F1A protein CTD PMID:33567340 dexamethasone multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP5F1A mRNA CTD PMID:28628672 dexamethasone increases expression ISO ATP5F1A (Homo sapiens) 6480464 Dexamethasone results in increased expression of ATP5F1A mRNA CTD PMID:25047013 diarsenic trioxide decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of ATP5F1A mRNA CTD PMID:15949261 diarsenic trioxide decreases expression ISO Atp5f1a (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of ATP5F1A mRNA CTD PMID:19422848 dibenzo[a,l]pyrene decreases expression ISO ATP5F1A (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in decreased expression of ATP5F1A protein CTD PMID:18495319 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of ATP5F1A mRNA CTD PMID:21266533 diclofenac multiple interactions EXP 6480464 [Diclofenac co-treated with lipopolysaccharide and E coli O55-B5] results in increased expression of ATP5F1A protein CTD PMID:25772430 diclofenac increases expression EXP 6480464 Diclofenac results in increased expression of ATP5F1A protein CTD PMID:25772430 dihydroartemisinin affects binding ISO ATP5F1A (Homo sapiens) 6480464 artenimol analog binds to ATP5F1A protein CTD PMID:26340163 dioxygen decreases expression ISO Atp5f1a (Mus musculus) 6480464 Oxygen deficiency results in decreased expression of ATP5F1A protein CTD PMID:25937538 doxorubicin decreases expression ISO Atp5f1a (Mus musculus) 6480464 Doxorubicin results in decreased expression of ATP5F1A mRNA and Doxorubicin results in decreased expression of ATP5F1A protein CTD PMID:26873546 more ... doxorubicin decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Doxorubicin results in decreased expression of ATP5F1A mRNA CTD PMID:29803840 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of ATP5F1A protein CTD PMID:26678157 enzyme inhibitor multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of ATP5F1A protein CTD PMID:23301498 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of ATP5F1A mRNA and Ethanol results in decreased expression of ATP5F1A protein CTD PMID:17618662 and PMID:23702218 ethanol multiple interactions ISO Atp5f1a (Mus musculus) 6480464 Ethanol affects the expression of and affects the splicing of ATP5F1A mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 [Dronabinol co-treated with Ethanol] results in decreased expression of ATP5F1A mRNA CTD PMID:17618662 fenvalerate decreases expression EXP 6480464 fenvalerate results in decreased expression of ATP5F1A protein CTD PMID:33656234 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ATP5F1A mRNA CTD PMID:18035473 flutamide decreases expression ISO Atp5f1a (Mus musculus) 6480464 Flutamide results in decreased expression of ATP5F1A mRNA CTD PMID:19442681 folic acid multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ATP5F1A mRNA CTD PMID:22206623 folpet increases expression ISO Atp5f1a (Mus musculus) 6480464 folpet results in increased expression of ATP5F1A mRNA CTD PMID:31558096 galactose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ATP5F1A mRNA CTD PMID:22061828 glucose multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 hyaluronic acid decreases expression EXP 6480464 Hyaluronic Acid analog results in decreased expression of ATP5F1A protein CTD PMID:23178681 hyaluronic acid multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP5F1A protein] CTD PMID:23178681 hydrogen peroxide multiple interactions EXP 6480464 Hyaluronic Acid analog inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP5F1A protein] CTD PMID:23178681 hydrogen peroxide multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 BMAL1 protein affects the reaction [Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP5F1A mRNA]] and Polyphenols inhibits the reaction [Hydrogen Peroxide results in decreased expression of ATP5F1A mRNA] CTD PMID:30316844 hydrogen peroxide decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of ATP5F1A mRNA CTD PMID:30316844 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of ATP5F1A protein CTD PMID:23178681 indometacin multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ATP5F1A mRNA CTD PMID:28628672 isoflavones multiple interactions EXP 6480464 [9 more ... CTD PMID:22248470 isopimaric acid decreases expression ISO Atp5f1a (Mus musculus) 6480464 isopimaric acid results in decreased expression of ATP5A1 protein CTD PMID:36754215 isoprenaline decreases expression ISO Atp5f1a (Mus musculus) 6480464 Isoproterenol results in decreased expression of ATP5F1A mRNA CTD PMID:20003209 isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ATP5F1A mRNA CTD PMID:30303030 ivermectin decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Ivermectin results in decreased expression of ATP5F1A protein CTD PMID:32959892 lenvatinib affects expression EXP 6480464 lenvatinib affects the expression of ATP5F1A protein CTD PMID:34019861 maneb multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of ATP5F1A protein more ... CTD PMID:23562983 methanol decreases expression EXP 6480464 Methanol results in decreased expression of ATP5F1A protein CTD PMID:22257634 methimazole increases expression EXP 6480464 Methimazole results in increased expression of ATP5F1A mRNA CTD PMID:30047161 minocycline multiple interactions ISO Atp5f1a (Mus musculus) 6480464 Minocycline inhibits the reaction [[Maneb co-treated with Paraquat] results in decreased expression of ATP5F1A protein] CTD PMID:23562983 mitoxantrone decreases expression ISO Atp5f1a (Mus musculus) 6480464 Mitoxantrone results in decreased expression of ATP5F1A protein CTD PMID:34246718 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1A mRNA CTD PMID:28659758 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Cadmium Chloride results in decreased expression of ATP5F1A mRNA] CTD PMID:36493885 N-methyl-4-phenylpyridinium affects expression ISO ATP5F1A (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium affects the expression of ATP5F1A mRNA CTD PMID:12710931 N-methyl-4-phenylpyridinium multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 MTERF3 protein promotes the reaction [1-Methyl-4-phenylpyridinium results in increased expression of ATP5A1 protein] CTD PMID:35904214 N-methyl-4-phenylpyridinium decreases expression ISO ATP5F1A (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of ATP5F1A protein CTD PMID:26102036 N-methyl-4-phenylpyridinium increases expression ISO ATP5F1A (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of ATP5A1 protein and 1-Methyl-4-phenylpyridinium results in increased expression of ATP5F1A protein CTD PMID:24675778 and PMID:35904214 N-nitrosomorpholine decreases expression EXP 6480464 N-nitrosomorpholine results in decreased expression of ATP5F1A protein CTD PMID:19716841 naphthalene decreases expression ISO Atp5f1a (Mus musculus) 6480464 naphthalene results in decreased expression of ATP5F1A protein CTD PMID:19438287 naphthalene multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [naphthalene co-treated with CFTR gene mutant form] results in decreased expression of ATP5F1A protein CTD PMID:19438287 niclosamide increases expression ISO ATP5F1A (Homo sapiens) 6480464 Niclosamide results in increased expression of ATP5F1A mRNA CTD PMID:22576131 nicotine decreases expression EXP 6480464 Nicotine results in decreased expression of ATP5F1A protein CTD PMID:28681937 nitroglycerin decreases expression EXP 6480464 Nitroglycerin results in decreased expression of ATP5F1A mRNA CTD PMID:12102619 Nivalenol decreases expression ISO Atp5f1a (Mus musculus) 6480464 nivalenol results in decreased expression of ATP5F1A mRNA CTD PMID:35016910 ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of ATP5F1A protein CTD PMID:31369848 okadaic acid decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Okadaic Acid results in decreased expression of ATP5F1A protein CTD PMID:19397276 ouabain affects expression ISO ATP5F1A (Homo sapiens) 6480464 Ouabain affects the expression of ATP5F1A protein CTD PMID:17268060 oxybenzone increases expression EXP 6480464 oxybenzone results in increased expression of ATP5F1A mRNA CTD PMID:30316929 ozone increases phosphorylation EXP 6480464 Ozone results in increased phosphorylation of ATP5F1A protein CTD PMID:33146391 paracetamol decreases expression ISO Atp5f1a (Mus musculus) 6480464 Acetaminophen results in decreased expression of ATP5F1A protein CTD PMID:11752693 and PMID:34401974 paracetamol increases expression ISO Atp5f1a (Mus musculus) 6480464 Acetaminophen results in increased expression of ATP5F1A protein CTD PMID:21329376 paracetamol affects expression ISO Atp5f1a (Mus musculus) 6480464 Acetaminophen affects the expression of ATP5F1A mRNA CTD PMID:17562736 paracetamol decreases expression ISO ATP5F1A (Homo sapiens) 6480464 Acetaminophen results in decreased expression of ATP5F1A mRNA CTD PMID:29067470 and PMID:31059760 paracetamol multiple interactions ISO Atp5f1a (Mus musculus) 6480464 Membrane Transport Modulators inhibits the reaction [Acetaminophen results in decreased expression of ATP5F1A protein] CTD PMID:34401974 paraquat multiple interactions ISO Atp5f1a (Mus musculus) 6480464 [Maneb co-treated with Paraquat] results in decreased expression of ATP5F1A protein more ... CTD PMID:23562983 PCB138 increases expression EXP 6480464 2 more ... CTD PMID:21673325 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1A mRNA CTD PMID:28659758 phenobarbital affects expression ISO ATP5F1A (Homo sapiens) 6480464 Phenobarbital affects the expression of ATP5F1A mRNA CTD PMID:19159669 phenobarbital affects expression ISO Atp5f1a (Mus musculus) 6480464 Phenobarbital affects the expression of ATP5F1A mRNA CTD PMID:23091169 phlorizin decreases expression ISO Atp5f1a (Mus musculus) 6480464 Phlorhizin results in decreased expression of ATP5F1A mRNA CTD PMID:22538082 pramipexole multiple interactions EXP 6480464 Pramipexole inhibits the reaction [amyloid beta-protein (1-42) results in decreased expression of ATP5F1A protein] CTD PMID:35868426 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1A mRNA CTD PMID:28659758 pyruvic acid multiple interactions EXP 6480464 [Glucose deficiency co-treated with Galactose co-treated with Pyruvic Acid] results in increased expression of ATP5F1A protein CTD PMID:25997894 quercetin affects binding ISO ATP5F1A (Homo sapiens) 6480464 Quercetin analog binds to ATP5F1A protein CTD PMID:21798748 regorafenib decreases expression EXP 6480464 regorafenib results in decreased expression of ATP5F1A protein CTD PMID:33166663 resveratrol multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of ATP5F1A mRNA CTD PMID:23557933 resveratrol multiple interactions ISO Atp5f1a (Mus musculus) 6480464 SIRT1 protein affects the reaction [Resveratrol results in increased expression of ATP5F1A mRNA] and STK11 protein affects the reaction [Resveratrol results in increased expression of ATP5F1A mRNA] CTD PMID:34216621 resveratrol increases expression ISO Atp5f1a (Mus musculus) 6480464 Resveratrol results in increased expression of ATP5F1A mRNA and Resveratrol results in increased expression of ATP5F1A protein CTD PMID:25394648 and PMID:34216621 rotenone increases oxidation EXP 6480464 Rotenone results in increased oxidation of ATP5F1A protein CTD PMID:30951809 rotenone increases expression EXP 6480464 Rotenone results in increased expression of ATP5F1A protein CTD PMID:35544339 silicon dioxide affects secretion ISO ATP5F1A (Homo sapiens) 6480464 Silicon Dioxide analog affects the secretion of ATP5F1A protein CTD PMID:25895662 sodium arsenate increases expression ISO Atp5f1a (Mus musculus) 6480464 sodium arsenate results in increased expression of ATP5F1A mRNA CTD PMID:30953684 sodium arsenite increases expression ISO ATP5F1A (Homo sapiens) 6480464 sodium arsenite results in increased expression of ATP5F1A protein CTD PMID:27908234 sodium arsenite increases expression ISO Atp5f1a (Mus musculus) 6480464 sodium arsenite results in increased expression of ATP5F1A protein CTD PMID:29044176 sodium arsenite affects methylation ISO ATP5F1A (Homo sapiens) 6480464 sodium arsenite affects the methylation of ATP5F1A gene CTD PMID:28589171 sodium fluoride increases expression ISO Atp5f1a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of ATP5F1A protein CTD PMID:27548804 sodium fluoride decreases expression ISO Atp5f1a (Mus musculus) 6480464 Sodium Fluoride results in decreased expression of ATP5F1A protein CTD PMID:27548804 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of ATP5F1A protein CTD PMID:21136691 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of ATP5F1A protein] CTD PMID:21136691 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of ATP5F1A mRNA CTD PMID:30047161 sunitinib decreases expression ISO Atp5f1a (Mus musculus) 6480464 Sunitinib results in decreased expression of ATP5F1A mRNA CTD PMID:31445075 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of ATP5F1A protein CTD PMID:26141394 tamoxifen affects expression ISO Atp5f1a (Mus musculus) 6480464 Tamoxifen affects the expression of ATP5F1A mRNA CTD PMID:17555576 tanespimycin multiple interactions ISO ATP5F1A (Homo sapiens) 6480464 [tanespimycin co-treated with VER 155008] results in increased expression of ATP5F1A protein CTD PMID:31370342 tetrachloromethane multiple interactions EXP 6480464 [Olive Oil analog co-treated with Carbon Tetrachloride] affects the expression of ATP5F1A protein CTD PMID:25303780 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ATP5F1A mRNA CTD PMID:31150632 thapsigargin increases expression ISO ATP5F1A (Homo sapiens) 6480464 Thapsigargin results in increased expression of ATP5F1A mRNA CTD PMID:22378314 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ATP5F1A mRNA CTD PMID:34492290 toluene affects expression EXP 6480464 Toluene affects the expression of ATP5F1A mRNA CTD PMID:21827849 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of ATP5F1A mRNA CTD PMID:14565619 Triptolide multiple interactions ISO Atp5f1a (Mus musculus) 6480464 7 and 3'-dihydroxy-4'-methoxyisoflavone inhibits the reaction [triptolide results in decreased expression of ATP5F1A protein] CTD PMID:36436616 Triptolide multiple interactions EXP 6480464 7 more ... CTD PMID:36436616 Triptolide decreases expression ISO Atp5f1a (Mus musculus) 6480464 triptolide results in decreased expression of ATP5F1A protein CTD PMID:36436616 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of ATP5F1A mRNA and triptolide results in decreased expression of ATP5F1A protein CTD PMID:36436616 zinc atom decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ATP5F1A mRNA CTD PMID:11717422 zinc(0) decreases expression EXP 6480464 Zinc deficiency results in decreased expression of ATP5F1A mRNA CTD PMID:11717422